Centre Hospitalier Regional De Marseille — Sponsor Intelligence | 22 EU Trials

Filter these 22 trials by condition, phase, country and more.

Open in Search →

22 Registered trials

13 Recruiting

6 Completed trials

5 Countries active

32 Unique IMPs

100% Results reported

Phase III

Phase II

Phase III: 5 Phase II: 13 Phase IV: 1 Phase I: 1 Phase I (Other): 1 Other: 1

Oversight events:

1 serious breach 1 temporary halt 1 urgent safety measure 8 corrective measures across 6 trials

View oversight register →

100%

6 of 6 completed trials have published summary results (EU CTR Article 37 — 12-month obligation).

View full Transparency Scoreboard →

Top indications

Crohn's disease 1 Non-small cell lung cancer 1 Malignant glioma 1 Febrile neutropenia 1 Crohn´s disease 1 Septic shock 1

Top IMPs

AUTOLOGOUS ADIPOSE TISSUE-DERIVED STROMAL VASCULAR FRACTION CELLS 5 AZACITIDINE 2 PIOGLITAZONE 2 SODIUM CHLORIDE, HUMAN SERUM ALBUMIN 5% 2 5-[4-[(2S,5S,11S,14R)-14-BENZYL-11-(CARBOXYMETHYL)-5-[3-(DIAMINOMETHYLIDENEAMINO)PROPYL]-3,6,9,12,15-PENTAOXO-1,4,7,10,13-PENTAZACYCLOPENTADEC-2-YL]BUTYLAMINO]-2-[4,7-BIS(CARBOXYMETHYL)-1,4,7-TRIAZONAN-1-YL]-5-OXOPENTANOIC ACID RADIOALLEBLED WITH GALLIUM-68 1 AMIODARONE HYDROCHLORIDE 1 ARGIPRESSIN 1 AUTOLOGOUS CORD BLOOD-DERIVED MONONUCLEAR CELLS 1 CELLULOSE, MICROCRYSTALLINE 1 CERALASERTIB 1 EVEROLIMUS 1 METHYLPREDNISOLONE HYDROGEN SUCCINATE 1

All trials

22 total

CANDIDATE THERAPIES IN COMBINATION OR SEQUENTIALLY WITH TYROSINE KINASE INHIBITORS IN CHRONIC PHASE CHRONIC MYELOGENOUS LEUKAEMIA (CP-CML) P… Pending

2024-516328-32-00 Phase II 1 country PIOGLITAZONE
A PRECISION MEDICINE RANDOMIZED TRIAL FOR PATIENTS WITH RELAPSED OR REFRACTORY T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA BASED ON A FUNCTIONAL APP… Pending

2024-516570-30-00 Phase II 5 countries AZACITIDINE; EVEROLIMUS; RECOMBINANT L-ASPARAGINASE; TOFACITINIB; VENETOCLAX
Efficacy of an empirical treatment with Amoxicillin-clavulanate (AC) compared to the combination Amoxicillin-clavulanate and Ciprofloxacin (… Pending

2025-520995-24-00 Phase III 1 country
Systematic Adjunction of Vasopressine in hyperkinetic Septic Shock patients: a prospective, randomized, double blind study. Recruiting

2024-513401-31-00 Phase III 1 country ARGIPRESSIN
Tolerance of local administration of cryopreserved autologous stromal vascular fraction combined with micrograft for the treatment of refrac… Recruiting

2024-519740-32-00 Phase II 1 country AUTOLOGOUS ADIPOSE TISSUE-DERIVED STROMAL VASCULAR FRACTION CELLS
Prophylactic Anti-aRrhythmic therapy with Amiodarone in critically ill patients admitted for an out-of-hospital Cardiac Arrest with initial … Recruiting

2023-510099-30-00 Phase III 1 country AMIODARONE HYDROCHLORIDE
Evaluation of Local Co-administration of Autologous ADIpose Derived Stromal Vascular Fraction With Microfat for Refractory Perianal CROHN’s … Recruiting

2024-517794-24-00 Phase II 1 country AUTOLOGOUS ADIPOSE TISSUE-DERIVED STROMAL VASCULAR FRACTION CELLS; SODIUM CHLORI…
NOVEL TREATMENT OF DIABETIC FOOT ULCER BY AUTOLOGOUS STROMAL VASCULAR FRACTION OF ADIPOSE TISSUE Recruiting

2024-516342-19-00 Phase II 1 country AUTOLOGOUS ADIPOSE TISSUE-DERIVED STROMAL VASCULAR FRACTION CELLS
RILUSCI Recruiting

2024-514882-20-00 1 country CELLULOSE, MICROCRYSTALLINE; RILUZOLE
Evaluation of the Efficacy of an Intra-articular Injection of Autologous Microfat Combined With Autologous Platelet-enriched Plasma in the T… Recruiting

2024-516239-28-00 Phase II 1 country PLATELET CONCENTRATE, AUTOLOGOUS MICROFAT
INNOVATIVE TREATMENT OF SCARRED VOCAL FOLDS BY LOCAL INJECTION OF AUTOLOGOUS ADIPOSE-DERIVED STROMAL VASCULAR FRACTION: EFFICACY VERSUS PLAC… Recruiting

2024-517384-24-00 Phase II 1 country AUTOLOGOUS ADIPOSE TISSUE-DERIVED STROMAL VASCULAR FRACTION CELLS; SODIUM CHLORI…
Phase 1 study of a Propranolol (HEMANGIOL®) and oral metronomic Vinorelbine (NAVELBINE®) combination on children and teenagers With Refracto… Recruiting

2024-517185-42-00 Phase I (Other) 1 country PROPRANOLOL HYDROCHLORIDE; VINORELBINE TARTRATE
Neonatal hypoxic ischemic encephalopathy : safety and feasibility study of a curative treatment with autologous cord blood stem cells (NEOST… Recruiting

2024-516421-30-00 Phase II 1 country AUTOLOGOUS CORD BLOOD-DERIVED MONONUCLEAR CELLS
Combination of ALpelisib and Trametinib in progressive REfractory Meningiomas Recruiting

2024-515836-61-00 Phase I 1 country
Evolution of the cardiac function during the follow-up of the anticancer immunotherapy inhibiting PD-1 Recruiting

2024-517403-36-00 Phase IV 1 country
Efficacy of adjuvant Imatinib in patients with intermediate-risk gastrointestinal stromal tumor with a high-risk Genomic Grade Index Recruiting

2024-515432-71-00 Phase III 1 country
CORTICOP_Comparison of corticosteroids versus placebo on duration of ventilatory support during severe acute exacerbations of COPD patients … Ended

2024-516651-41-00 Phase III 1 country METHYLPREDNISOLONE HYDROGEN SUCCINATE; SODIUM CHLORIDE
OPEN LABEL PHASE 2 STUDY ON THE EFFICACY AND TOLERANCE OF A COMBINATION OF PONATINIB AND 5-AZACITIDINE IN CHRONIC MYELOGENOUS LEUKAEMIA IN A… Ended

2024-516048-24-00 Phase II 1 country AZACITIDINE; PONATINIB
PIO2STOP_Combination study of Pioglitazone and Tyrosine Kinase Inhibitors (TKIs) in Chronic Myeloid Leukemia patients after failure of a TKI… Ended

2024-515460-31-00 Phase II 1 country PIOGLITAZONE
Safety and potential effect of innovative treatment by adjuvant injection of stromal vascular Fraction from autologous adipose tissue of URe… Halted

2024-513306-65-00 Phase II 1 country AUTOLOGOUS ADIPOSE TISSUE-DERIVED STROMAL VASCULAR FRACTION CELLS
Molecular imaging exploration of ocular angiogenic activity and evaluation of its value in therapeutic follow-up of AMD patients Ended

2024-516970-31-00 Phase II 1 country 5-[4-[(2S,5S,11S,14R)-14-BENZYL-11-(CARBOXYMETHYL)-5-[3-(DIAMINOMETHYLIDENEAMINO…
Precision Immuno-Oncology for advanced Non-small cell lung cancer patients with PD-1 ICI Resistance (PIONeeR clinical study) Ended

2024-515532-72-00 Phase II 1 country CERALASERTIB; MONALIZUMAB; OLECLUMAB; SAVOLITINIB

Showing 1–22 of 22 trials

← All sponsors A–Z